Clinical Practice Guidelines
The Medical and Scientific Advisory Committee of the Alpha-1 Foundation has released new clinical recommendations designed to guide doctors on how to properly diagnose and treat Alpha-1 Antitrypsin Deficiency (Alpha-1) in adults.
The Clinical Practice Guidelines, based on the latest evidence and six years of work, recommend best practices on testing for Alpha-1, Alpha-1 lung and liver disease, and when augmentation therapy should be prescribed, among other recommendations. The guidelines are intended to update a 2003 document from the American Thoracic Society (ATS) and the European Respiratory Society on the diagnosis and management of Alpha-1.
Please read the Clinical Practice Guidelines - The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the Adult as published in the Journal of the COPD Foundation in July 2016.
Robert A. Sandhaus, MD, PhD, one of the authors of the Clinical Practice Guidelines, gave an overview and answered questions and concerns about the guidelines at the 2016 Alpha-1 National Education Conference. View the video below:
New Guidelines for the Diagnosis and Treatment of Alpha-1. How will they affect me? from Alpha-1 Foundation on Vimeo.
Could it be Alpha-1? - A Diagnosis Story